On July 6, 2012, the US Department of Health and Human Services Office of the Inspector General’s (“OIG”) Office of Evaluation and Inspections issued a report (OEI-07-08-00151) entitled “Nursing Facility Assessments and Care Plans for Residents Receiving Atypical Antipsychotic Drugs.”
The new study analyzes nursing facility assessments and care plans for residents receiving atypical antipsychotic medications. The study utilized a random sample of records derived from a previous OIG study of elderly nursing facility residents with Medicare claims for atypical antipsychotic drugs between January and June 2007 . The study concluded that 99% of the records failed to meet the federal requirements for care plans and/or assessments.
In its report, the OIG recommended to the Centers for Medicare and Medicaid Services (CMS) that it work to: 1) improve the detection of noncompliance for requirements for resident assessments and care plans for residents receiving antipsychotic drugs, 2) take appropriate action to address noncompliance with these requirements, and 3) provide methods for nursing facilities to enhance the development and usefulness of resident assessments and care plans.
Expect more to come in the future regarding antipsycotic medication and nursing home residents. This area is a clear target of the OIG and CMS for reduction of medication use for elderly residents with dementia and other cognitive impairments without diagnoses that directly support the use of antipsychotic medications.
You can find a copy of the OIG’s report here —> OEI-07-08-00151